Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.

Massat NJ, Moss SM, Halloran SP, Duffy SW.

J Med Screen. 2013;20(3):125-48. doi: 10.1177/0969141313501292. Review.

PMID:
24197771
2.

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089.

PMID:
19671542
3.

Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.

Tinmouth J, Lansdorp-Vogelaar I, Allison JE.

Gut. 2015 Aug;64(8):1327-37. doi: 10.1136/gutjnl-2014-308074. Epub 2015 Jun 3. Review.

PMID:
26041750
4.

Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Hewitson P, Glasziou P, Irwig L, Towler B, Watson E.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001216. Review.

PMID:
17253456
5.

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).

Denis B, Gendre I, Aman F, Ribstein F, Maurin P, Perrin P.

Eur J Cancer. 2009 Dec;45(18):3282-90. doi: 10.1016/j.ejca.2009.06.015. Epub 2009 Aug 6.

PMID:
19665368
6.

Evidence for colorectal cancer screening.

Bretthauer M.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Review.

PMID:
20833346
7.

Colorectal cancer screening.

Bretthauer M.

J Intern Med. 2011 Aug;270(2):87-98. doi: 10.1111/j.1365-2796.2011.02399.x. Epub 2011 Jun 9. Review.

8.

Options for screening for colorectal cancer.

Atkin W.

Scand J Gastroenterol Suppl. 2003;(237):13-6. Review.

PMID:
12797674
9.

Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy.

Sharp L, Tilson L, Whyte S, O'Ceilleachair A, Walsh C, Usher C, Tappenden P, Chilcott J, Staines A, Barry M, Comber H.

Br J Cancer. 2012 Feb 28;106(5):805-16. doi: 10.1038/bjc.2011.580. Epub 2012 Feb 16.

10.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
12.

A population-based estimate of the extent of colorectal cancer screening in Ontario.

Rabeneck L, Paszat LF.

Am J Gastroenterol. 2004 Jun;99(6):1141-4.

PMID:
15180738
13.

Systematic review of the effectiveness of population screening for colorectal cancer.

Kerr J, Day P, Broadstock M, Weir R, Bidwell S.

N Z Med J. 2007 Jul 20;120(1258):U2629. Review.

PMID:
17653247
14.

Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy..

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.

PMID:
15741571
15.

Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.

Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, Reijerink JC, Habbema JD, Essink-Bot ML, Kuipers EJ.

Eur J Cancer. 2010 Jul;46(11):2059-66. doi: 10.1016/j.ejca.2010.03.022. Epub 2010 Jun 4.

PMID:
20621736
16.

Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.

Shroff J, Thosani N, Batra S, Singh H, Guha S.

World J Gastroenterol. 2014 Dec 28;20(48):18466-76. doi: 10.3748/wjg.v20.i48.18466. Review.

17.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
18.

Anatomic distribution of cancers and colorectal adenomas according to age and sex and relationship between proximal and distal neoplasms in an i-FOBT-positive average-risk Italian screening cohort.

Parente F, Bargiggia S, Boemo C, Vailati C, Bonoldi E, Ardizzoia A, Ilardo A, Tortorella F, Gallus S.

Int J Colorectal Dis. 2014 Jan;29(1):57-64. doi: 10.1007/s00384-013-1759-9. Epub 2013 Aug 24.

PMID:
23975054
19.

Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.

Zorzi M, Fedeli U, Schievano E, Bovo E, Guzzinati S, Baracco S, Fedato C, Saugo M, Dei Tos AP.

Gut. 2015 May;64(5):784-90. doi: 10.1136/gutjnl-2014-307508. Epub 2014 Sep 1.

PMID:
25179811
20.

Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).

Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G.

Scand J Gastroenterol. 2002 May;37(5):568-73.

PMID:
12059059

Supplemental Content

Support Center